Abveris Deploys the Berkeley Lights Beacon® Platform for Antibody Discovery
CANTON, Mass.–(BUSINESS WIRE)–Abveris, Inc., a leader in contract research antibody discovery, today announced the deployment of the Berkeley Lights, Inc.…
Pharmaceuticals, Biotechnology and Life Sciences
CANTON, Mass.–(BUSINESS WIRE)–Abveris, Inc., a leader in contract research antibody discovery, today announced the deployment of the Berkeley Lights, Inc.…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Compass Therapeutics, a clinical-stage biotechnology company targeting the human immune synapse with a new generation of monoclonal and…
Leveraging innovative technology to orchestrate cross functional teamwork and multichannel interactions with external stakeholders DANBURY, Conn. & RESEARCH TRIANGLE PARK,…
VT-1161 is a potent antifungal therapy with the potential to treat a range of fungal infections, including those resistant to…
SAN FRANCISCO–(BUSINESS WIRE)–#DNA–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA…
Additions strengthen management team and position company to advance portfolio of medicines targeting RNA-mediated diseases into the clinic SAN DIEGO–(BUSINESS…
Company Co-Founder and Chief Technology Officer Receives Distinguished Judith Stitt Best Abstract Award for Data Presented at the American Brachytherapy…
Findings will support application for European marketing authorization and augment body of data supporting efficacy and utility of its ready-to-use,…
Funding to support regulatory filing and pre-commercial planning for lead product candidate, inebilizumab, and to advance development of additional clinical…
− On Track to Report ILLUMINATE-A Topline Results in Late 2019 – − In Addition, Company Reports Final Positive Results…